Clinical trial
Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery
NCT00130715 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00130715 |
|---|---|
| Title | Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery |
| Official title | A Prospective, Randomized, Multicenter, Controlled Evaluation of the Efficacy and Safety of Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Intestinal Obstruction, Digestive System Surgical Procedures |
| Intervention type | Device |
| Interventions | Seprafilm Bioresorbable Membrane |
| Start date | Jun 1, 1998 |
| Completion | Aug 1, 2003 |
| First posted | Aug 16, 2005 |
| Last update posted | Mar 12, 2015 |
| Countries | Canada, Germany, Netherlands, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: